Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR*D trial
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
CONTEXT: Outcomes of antidepressant medication treatment for major depressive disorder include remission, response, and nonresponse. But nonresponse can include depression that worsened over the course of treatment, an outcome that has received scant attention. OBJECTIVE: To describe baseline sociodemographic, clinical, and treatment characteristics associated with worsened depression during a trial of citalopram. DESIGN, PARTICIPANTS, AND SETTINGS: Open-label clinical trial of 2,876 adult outpatients seen in 18 primary and 23 psychiatric-care settings. INTERVENTION: Citalopram was delivered using measurement-based care and flexible dosing with the aim of achieving symptom remission. Symptom and side effect ratings were obtained at each treatment visit. MAIN OUTCOME MEASURES: Worsened depression was defined as an exit score >or=3 points above the pretreatment (baseline) score on the 16-item QIDS-SR. Baseline sociodemographic, clinical, and treatment characteristics were examined for association with worsened depression. RESULTS: Of 2,864 outpatients who returned for >or=2 post baseline visits, 150 (5.2%) had worsened depression at study exit. Baseline characteristics independently associated with increased worsened depression included African-American race (OR=2.02), having less than a college education (OR=2.36), posttraumatic stress disorder (OR=1.78), drug abuse (OR=1.97), hypochondriasis (OR=2.74). Participants with worsened depression spent less time in treatment; had fewer treatment visits; exited the study sooner; had more frequent, intense, and burdensome adverse effects; and were more intolerant of medication. CONCLUSIONS: The presence of certain baseline characteristics indicated a greater likelihood of worsened depression during antidepressant treatment. Patients with these characteristics should be monitored closely during treatment and may be candidates for more aggressive treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Socioeconomic inequalities in depression: a meta-analysis
Lorant, V. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf182 · Cited by 2,603 · cited 2×
“A meta-analysis of prevalence, incidence, and persistence studies by Lorant et al.[35] found low levels of education and income to be modifiers of the association between low socioeconomic status and depression.”
BackgroundUnützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 6×
“The CRC also completed the 14-item Cumulative Illness Rating Scale (CIRS)[27,28] to gauge the severity/morbidity of GMCs relevant to different organ systems.”
MethodInfluentialSocioeconomic Status and Health: What We Know and What We Don't
ADLER, N. E., & OSTROVE, J. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08101.x · Cited by 1,643 · cited 1×
“Sociodemographic characteristics such as lower socioeconomic status have long been associated with elevated rates of illness morbidity and mortality compared to individuals with higher socioeconomic status.([32,33]) Kessler et al.”
BackgroundSequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 5×
“The Sequenced Treatment Alternatives to Relieve Depression (STAR D) trial([9,10]) was the first large scale, ecologically valid study to define remission a priori as the primary endpoint.”
BackgroundMethodInfluentialSelf-citationTRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 3×
“[20] Responses to items on the baseline 30-item Inventory of Depressive Symptomatology—Clinician-rated (IDS-C30) [13,15,21] or the HRSD17 obtained by the ROA were used to determine the presence of atypical,[22] anxious,[23–25] and melancholic[26] symptom features.”
MethodSelf-citationFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Self-citationKrueger, R. F., Markon, K. E., Patrick, C. J., Benning, S. D., & Kramer, M. D. (2007) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.116.4.645 · Cited by 861 · cited 1×
“Some have suggested that substance abusers are disposed toward externalizing behaviors, particularly increased impulsivity, which may contribute to reduced treatment adherence.([44]) This report adds to these previous reports by providing new information suggesting that SSRI treatment in patients with co-occurring dru…”
ResultReport by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Self-citationPsychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470
Rush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427
Self-citationFAVA, M., ALPERT, J. E., CARMIN, C. N., WISNIEWSKI, S. R., TRIVEDI, M. H., BIGGS, M. M., SHORES-WILSON, K., MORGAN, D., SCHWARTZ, T., BALASUBRAMANI, G. K., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291704002612 · Cited by 406
Self-citationZimmerman, M., & Mattia, J. I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.787 · Cited by 375 · cited 2×
“The Psychiatric Diagnostic Screening Questionnaire (PDSQ)([18,19]) was completed at baseline to identify the presence of 11 potential concurrent Axis I (psychiatric) disorders, using a 90% specificity threshold.”
MethodTreating minority patients with depression and anxiety: What does the evidence tell us?
Schraufnagel, T. J., Wagner, A. W., Miranda, J., & Roy-Byrne, P. P. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.07.002 · Cited by 205
Fava, M., Rush, A. J., Alpert, J. E., Carmin, C. N., Balasubramani, G., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., & Shores-Wilson, K. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101304 · Cited by 183
Self-citationCusin, C., Fava, M., Amsterdam, J. D., Quitkin, F. M., Reimherr, F. W., Beasley, C. M., Rosenbaum, J. F., & Perlis, R. H. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0107 · Cited by 22
Self-citation
Cited by
Gadad, B. S., Jha, M. K., Czysz, A., Furman, J. L., Mayes, T. L., Emslie, M. P., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.001 · Cited by 205
Self-citationPhysical Exercise and Neuroinflammation in Major Depressive Disorder
Ignácio, Z. M., da Silva, R. S., Plissari, M. E., Quevedo, J., & Réus, G. Z. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01670-1 · Cited by 153
Brand, B. L., McNary, S. W., Myrick, A. C., Classen, C. C., Lanius, R., Loewenstein, R. J., Pain, C., & Putnam, F. W. (2013) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0027654 · Cited by 149
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
“Interestingly, this was the patient group that experienced more frequent, intense, and burdensome adverse effects [39].”
BackgroundCarter, G. C., Cantrell, R. A., Zarotsky, V., Haynes, V. S., Phillips, G., Alatorre, C. I., Goetz, I., Paczkowski, R., & Marangell, L. B. (2012) · Depression and Anxiety · doi:10.1002/da.21918 · Cited by 109
Metadata
- Authors
- Friedman, E. S., Wisniewski, S. R., Gilmer, W., Nierenberg, A. A., Rush, A. J., Fava, M., Zisook, S., Balasubramani, G. K., & Trivedi, M. H.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2009-07
- Volume
- 26
- Issue
- 7
- Pages
- 612-621
- ISSN
- 1091-4269 (ISSN-L)
- 1520-6394
- OpenAlex
- W2092622512
- Cited by
- 29
- References
- 17
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.